Powered by Smartsupp

Alzheimer’s disease: symptoms, diagnosis and vascular health

KINGRAY Academy · educational series on the heart, blood and blood vessels.

What are the early signs of Alzheimer’s?

Alzheimer's disease is a progressive brain disease and the most common cause of dementia. It can gradually affect memory, thinking, orientation and independence. It is not a normal part of ageing.

We explain the difference between Alzheimer's disease and dementia, changes that warrant assessment, and links with vascular health. In discussing 40 Hz light and sound stimulation, we distinguish pilot study findings from evidence of treatment effectiveness.

Author: Ing. František Kokoš · Updated:
First published:

For practical comparisons when choosing, visit our advice guides: Advice: heart and circulation → · Advice: memory and focus →

01 · What is Alzheimer's disease?

Illustration of Alzheimer’s disease; this image is not a diagnostic examination.
Illustration of Alzheimer’s disease; this image is not a diagnostic examination.

Alzheimer's disease is a progressive brain disease and the most common cause of dementia. Dementia describes a group of symptoms affecting memory, thinking and everyday functioning. Not every memory problem means Alzheimer's disease, and the disease is not a normal part of ageing. [1]

Progression and support needs vary between individuals. This article provides an introduction; it does not establish a diagnosis or a plan for an individual patient.

Alzheimer's disease and dementia are not synonyms

Terms and their meanings

Dementia — A group of symptoms affecting cognitive abilities and everyday functioning. It can have various causes.

Alzheimer's disease — One cause of dementia, involving progressive damage to nerve cells and their connections.

Vascular dementia — Associated with brain damage caused by problems with its blood supply.

Mixed dementia — Alzheimer's-related and vascular changes may occur together in one person.

Scientific sources: [1], [7], [8].

02 · Which changes should you watch for?

Gradually worsening difficulties may warrant assessment, for example:

  • repeatedly forgetting recent conversations or events,
  • becoming disoriented even in familiar places,
  • difficulty planning and making decisions,
  • problems expressing oneself or carrying out routine activities,
  • marked changes in behaviour and mood.

A symptom list alone is insufficient for diagnosis. How symptoms develop and affect independence matters. [1]

Fatigue, stress and sleep can affect memory and concentration. However, new or progressively worsening difficulties need individual assessment.

03 · How is it diagnosed?

The first step is a discussion with a doctor. Bringing someone close who can describe specific changes may help. The doctor reviews symptoms, health and medicines, and may recommend cognitive tests, laboratory investigations or specialist assessment. Further evaluation may include a brain CT or MRI scan. [2]

Depression, anxiety, stress, medicines and some hormonal or nutritional disorders can also affect memory. It is important to investigate the cause rather than attribute every problem to age. A memory test result should not be assessed in isolation. [2]

Prepare a list of medicines and supplements, examples of difficulties and their approximate onset. The doctor decides on the next steps.

Specialist assessment may also use amyloid- and tau-related biomarkers, for example through PET imaging or testing biological samples. A doctor must interpret them alongside symptoms and other findings. A home memory test does not replace them.

Scientific sources: [7].

04 · Vascular health, sleep and risk factors

Alongside age, dementia risk is associated with high blood pressure, diabetes, smoking, physical inactivity, impaired hearing and vision, depression and social isolation. WHO also lists poor sleep. A risk factor is neither a diagnosis nor proof of a cause in an individual. [3]

Looking after overall health includes appropriate activity, a balanced diet, not smoking, social contact and managing blood pressure, cholesterol and glucose. These measures do not guarantee that Alzheimer's disease will not develop. [3]

What is being studied in the brain?

Characteristic changes in Alzheimer's disease include beta-amyloid deposits between nerve cells and changes in tau protein inside cells. Researchers study their interactions and the roles of inflammation, metabolism and blood vessels.

Amyloid plaques and atherosclerotic plaques are different. Amyloid plaques are protein deposits in the brain; atherosclerotic plaques form in artery walls. Alzheimer's disease cannot be reduced to “blocked vessels” or “thick blood”.

Vascular damage may worsen brain health and coexist with Alzheimer's-related changes. Research into these mechanisms does not justify changing medicines independently or using methods promising to “clean the brain”.

Scientific sources: [7], [8].

Illustration of the relationship between vascular health and brain function.
Illustration of the relationship between vascular health and brain function.

Alzheimer’s disease gradually damages nerve cells and their connections. Amyloid and tau changes interact with inflammatory and metabolic processes. Vascular damage may coexist: impaired microcirculation can worsen oxygen and nutrient delivery, while blood–brain barrier changes may affect the removal of some proteins. Caring for blood vessels is therefore part of caring for the brain. [7]

Action is worthwhile before memory difficulties appear: regular movement, a varied diet, not smoking, limiting alcohol and controlling blood pressure, glucose and cholesterol. Sleep, addressing hearing and vision loss, learning and social contact also matter. These measures address several dementia risk factors. Even after disease develops, appropriate activity, nutrition and support from others remain important for daily functioning. [3]

05 · What does research on light and 40 Hz mean?

A 2022 pilot study investigated combined light and sound stimulation at 40 Hz. The randomised portion included 15 people with mild probable Alzheimer's dementia. Its main aim was to assess safety, adherence and brain responses. The study lacked sufficient statistical power to reliably assess differences in exploratory clinical outcomes. [4]

Such findings do not prove that a home light or commercial device treats Alzheimer's disease. The same frequency alone does not establish equivalent devices, safety or effects. This article does not recommend light stimulation at home.

A research hypothesis, a measurable brain response and a demonstrated benefit in a patient's everyday life are different things.
Illustration of brain cell research; 40 Hz sensory stimulation remains under investigation.
Illustration of brain cell research; 40 Hz sensory stimulation remains under investigation.

The MIT pilot study described is registered as NCT04055376. The public registry provides access to its protocol and recorded information. Registration or an ongoing study does not in itself mean that a method is an approved treatment or that its effectiveness has been established. [6]

What does 40 Hz mean?

In this research, 40 Hz means sensory stimuli repeated 40 times per second. It is not a light wavelength, which may be expressed in nanometres. Sensory stimulation and photobiomodulation are different methods.

Results from one method cannot automatically be transferred to another.

Scientific sources: [4].

In a pilot randomised study of combined 40 Hz light and sound stimulation in 15 people with mild Alzheimer’s dementia, exploratory results after three months included better face–name association performance and less hippocampal volume loss than in the control group. The small study primarily assessed safety and feasibility; these findings alone do not establish treatment efficacy. Sensory light and sound stimulation is distinct from transcranial photobiomodulation. [4]

Transcranial photobiomodulation applies light through the scalp. A 2026 randomised, double-blind, placebo-controlled trial included 80 participants with mild cognitive impairment due to Alzheimer’s disease. After 12 weeks of 808 nm application, mean MoCA-K scores rose by 3.87 points in the active group and fell by 0.74 points in the control group. This supports further investigation; the long-term effect on disease progression remains to be established. [9]

In simple terms: A better memory-test result in one trial does not establish slower disease progression. 40 Hz sensory stimulation and photobiomodulation are different methods.

06 · Overview: what can be concluded?

Information and its limits

Worsening memory — A reason for assessment, not an automatic diagnosis.

Cognitive testing — Part of a broader professional assessment.

Health risks — Addressing them matters; prevention cannot be guaranteed.

40 Hz pilot study — Does not justify applying its conclusions to home devices.

07 · Supporting the person and their family

Clear communication, help with daily activities and support tailored to the person's needs are important. Families can discuss home safety, care arrangements and available social support with professionals. Caregiver exhaustion and their need for rest also deserve attention. [3]

Professional care is planned individually. This overview does not recommend particular medicines, supplements or devices.

Nutrition is part of care but does not replace diagnosis and a treatment plan.

08 · When should you seek help?

Arrange a medical appointment if memory, orientation or independence gradually worsen. [1]

A sudden change requires a prompt response. For sudden confusion, speech difficulties, weakness on one side of the body or impaired consciousness, call 112. Do not wait for a scheduled memory assessment. [5]

09 · Frequently asked questions about Alzheimer's disease

Does every decline in memory mean Alzheimer's disease?

No. Memory difficulties can have various causes. If they worsen or interfere with daily life, professional assessment is appropriate.

Is one memory test enough for a diagnosis?

No. A doctor reviews symptoms, health and medicines, adding cognitive tests, laboratory investigations and imaging when needed.

Does the 40 Hz pilot study prove a treatment for Alzheimer's disease?

No. The small pilot study mainly examined safety and brain responses. Its findings do not establish the effectiveness of home devices or treatment of the disease.

When should a change in condition prompt an immediate emergency call?

For sudden speech difficulties, weakness on one side, sudden confusion or impaired consciousness, call 112.

What is the difference between Alzheimer's disease and dementia?

Dementia describes symptoms affecting thinking and everyday functioning. Alzheimer's disease is one cause. Dementia can also involve vascular damage or a combination of processes.

Are amyloid plaques the same as vascular plaques?

No. Amyloid plaques are beta-amyloid protein deposits in the brain, whereas atherosclerotic plaques form in artery walls. Both processes may occur in one person, but they are not identical.

Does controlling blood pressure and glucose guarantee Alzheimer's prevention?

No. Addressing vascular and metabolic risks supports overall health and dementia risk reduction, but does not guarantee that Alzheimer's disease will not develop.

Scientific sources: [1] [2] [3] [4] [5] [7] [8]

KINGRAY girl – illustrated Advice mascot
Your KINGRAY Advice guide · illustration.

Looking for guidance on nutrition for your heart or brain?

Continue from our articles on blood and blood vessels to two practical advice guides. Choose a topic to compare supplement ingredients, daily amounts and precautions.

Heart, blood vessels and circulation

Need help comparing supplements in the heart and circulation category? Our guide compares ingredients, their forms and amounts per daily serving, with precautions about taking them alongside medicines.

Open the heart and circulation guide →

Brain, memory and cognitive function

Interested in memory, focus and mental performance? Our guide helps you compare supplement ingredients and distinguish authorised health claims from general promises.

Open the memory and focus guide →

The Academy explains the science; our advice guides help with practical choices. Supplements do not replace a varied diet, medical assessment or prescribed treatment.

Scientific sources

Scientific sources
  1. [1] NHS: Alzheimer's disease – overview Open source ↗
  2. [2] NHS: Diagnosing Alzheimer's disease Open source ↗
  3. [3] WHO: Dementia Open source ↗
  4. [4] Chan et al., 2022: pilot studies of 40 Hz sensory stimulation Open source ↗
  5. [5] NHS: Stroke symptoms Open source ↗
  6. [6] ClinicalTrials.gov – NCT04055376: study of daily light and sound stimulation in Alzheimer's disease. Open source ↗
  7. [7] NIH / NIA: What Happens to the Brain in Alzheimer’s Disease? Open source ↗
  8. [8] NHS: Vascular dementia Open source ↗
  9. [9] Chun H. et al. (2026). Home-based transcranial photobiomodulation improves cognitive function in mild cognitive impairment due to Alzheimer’s disease: A randomized, double-blind, placebo-controlled confirmatory trial. Open source ↗

Educational information: This article does not replace individual medical assessment, diagnosis or treatment. Discuss health concerns and memory changes with a doctor. Do not change or stop prescribed treatment based on this article.

Links and citations checked on 7 November 2026.

Ing. František Kokoš
Author: Ing. František Kokoš

Ing. František Kokoš – author for KINGRAY Academy and Advice

Nutritional counsellor, author of Liečba svetlom (Light Therapy; ISBN 978-80-970512-0-4) and co-author of BIOquant – polovodičová laserová terapia (Semiconductor Laser Therapy; ISBN 978-80-970512-2-8). He has worked with laser and light technologies and device development since 2008. He is named as the inventor in US patent US9731145B2 and as a co-inventor of the Slovak nasal applicator utility model SK5457Y1.

Ing. František Kokoš – education, publications and inventions →

%s ...
%s
%image %title %code %s
%s